minimal Common Oncology Data Elements (mCODE) Implementation Guide
2.0.0 - STU 2

This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v2.0.0: STU 2) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Table of Contents

..0 Table of Contents
...1 Home
...2 Patient Information
...3 Disease Characterization
...4 Assessment
...5 Genomics
...6 Treatments
...7 Outcomes
...8 Conformance Expectations
...9 Identifying In-Scope Patients
...10 Profile Conformance
...11 Terminology
...12 Profiles
...13 Extensions
...14 Value Sets
...15 Code Systems
...16 Capability Statements
...17 Artifacts Summary
....17.1 mcode-receiver-cancer-conditions-then-patients
....17.2 mcode-receiver-patient-bundle
....17.3 mcode-receiver-patients-and-cancer-conditions
....17.4 mcode-receiver-patients-in-group
....17.5 mcode-receiver-patients-with-cancer-condition
....17.6 mcode-sender-cancer-conditions-then-patients
....17.7 mcode-sender-patient-bundle
....17.8 mcode-sender-patients-and-cancer-conditions
....17.9 mcode-sender-patients-in-group
....17.10 mcode-sender-patients-with-cancer-condition
....17.11 mcode-patient-everything
....17.12 Comorbidities Parent Abstract Profile
....17.13 Cancer Disease Status Profile
....17.14 Cancer Patient Profile
....17.15 Cancer-Related Medication Administration Profile
....17.16 Cancer-Related Medication Request Profile
....17.17 Cancer-Related Surgical Procedure Profile
....17.18 Cancer Stage Group Profile
....17.19 Comorbidities Elixhauser Profile
....17.20 ECOG Performance Status Profile
....17.21 Genomic Region Studied Profile
....17.22 Genomic Specimen Profile
....17.23 Genomic Variant Profile
....17.24 Genomics Report Profile
....17.25 Karnofsky Performance Status Profile
....17.26 mCODE Patient Bundle Profile
....17.27 mCODE Patient Group Profile
....17.28 Primary Cancer Condition Profile
....17.29 Radiotherapy Course Summary Profile
....17.30 Radiotherapy Volume Profile
....17.31 Secondary Cancer Condition Profile
....17.32 TNM Distant Metastases Category Profile
....17.33 TNM Primary Tumor Category Profile
....17.34 TNM Regional Nodes Category Profile
....17.35 Tumor Profile
....17.36 Tumor Marker Test Profile
....17.37 Tumor Size Profile
....17.38 Tumor Specimen Profile
....17.39 Body Structure Identifier Data Type Profile
....17.40 Body Location Qualifier Extension
....17.41 Cancer Disease Status Evidence Type Extension
....17.42 Comorbid Condition Code Extension
....17.43 Comorbid Condition Reference Extension
....17.44 Histology-Morphology-Behavior Extension
....17.45 Laterality Qualifier Extension
....17.46 Procedure Intent Extension
....17.47 Radiotherapy Dose Delivered To Volume Extension
....17.48 Radiotherapy Modality Extension
....17.49 Radiotherapy Modality And Technique Extension
....17.50 Radiotherapy Number of Sessions Extension
....17.51 Radiotherapy Technique Extension
....17.52 Related Condition Extension
....17.53 Treatment Termination Reason Extension
....17.54 Benign Neoplasm of Brain and CNS Disorder Value Set
....17.55 Body Location and Laterality Qualifier Value Set
....17.56 Body Location Qualifier Value Set
....17.57 Brachytherapy High Dose Rate Electronic Technique Value Set
....17.58 Brachytherapy High Dose Rate Technique Value Set
....17.59 Brachytherapy Low Dose Rate Temporary Radation Technique Value Set
....17.60 Brachytherapy Modality Value Set
....17.61 Brachytherapy Permanent Seeds Technique Value Set
....17.62 Brachytherapy Pulsed Dose Rate Technique Value Set
....17.63 Brachytherapy Radiopharmaceutical Technique Value Set
....17.64 Brachytherapy Technique Value Set
....17.65 Cancer Body Location Value Set
....17.66 Cancer Disease Status Evidence Type Value Set
....17.67 Cancer Disorder Value Set
....17.68 Cancer-Related Surgical Procedure Value Set
....17.69 Cancer Stage Group Value Set
....17.70 Cancer Staging System Value Set
....17.71 Carcinoma In-Situ Disorder Value Set
....17.72 ClinVar Value Set
....17.73 Condition Status Trend Value Set
....17.74 Cytologic Evidence of Malignancy Value Set
....17.75 DNA Change Type Value Set
....17.76 Elixhauser HIV-AIDS Value Set
....17.77 Elixhauser Alcohol Abuse Value Set
....17.78 Elixhauser Blood Loss Anemia Value Set
....17.79 Elixhauser Leukemia Value Set
....17.80 Elixhauser Lymphoma Value Set
....17.81 Elixhauser Metastatic Cancer Value Set
....17.82 Elixhauser Malignant Solid Tumors In Situ Value Set
....17.83 Elixhauser Malignant Solid Tumors Without Metastases Value Set
....17.84 Elixhauser Cerebrovascular Disease Value Set
....17.85 Elixhauser Chronic Pulmonary Disease Value Set
....17.86 Elixhauser Coagulation Deficiency Value Set
....17.87 Elixhauser Congestive Heart Failure Value Set
....17.88 Elixhauser Deficiency Anemia Value Set
....17.89 Elixhauser Dementia Value Set
....17.90 Elixhauser Depression Value Set
....17.91 Elixhauser Diabetes With Chronic Complications Value Set
....17.92 Elixhauser Diabetes Without Chronic Complications Value Set
....17.93 Elixhauser Drug Abuse Value Set
....17.94 Elixhauser Hypertension, Complicated Value Set
....17.95 Elixhauser Hypertension, Uncomplicated Value Set
....17.96 Elixhauser Hypothyroidism Value Set
....17.97 Elixhauser Mild Liver Disease Value Set
....17.98 Elixhauser Moderate To Severe Liver Disease Value Set
....17.99 Elixhauser Neurological Movement Disorder Value Set
....17.100 Elixhauser Neurological Seizure Disorder Value Set
....17.101 Elixhauser Obesity Value Set
....17.102 Elixhauser Other Neurological Disorder Value Set
....17.103 Elixhauser Other Thyroid Disorder Value Set
....17.104 Elixhauser Paralysis Value Set
....17.105 Elixhauser Peripheral Vascular Disease Value Set
....17.106 Elixhauser Psychosis Value Set
....17.107 Elixhauser Pulmonary Circulation Disorder Value Set
....17.108 Elixhauser Moderate Renal Failure Value Set
....17.109 Elixhauser Severe Renal Failure Value Set
....17.110 Elixhauser Rheumatoid Arthritis and Collagen Vascular Disease Value Set
....17.111 Elixhauser Chronic Peptic Ulcer Disease Value Set
....17.112 Elixhauser Valvular Disease Value Set
....17.113 Elixhauser Weight Loss Value Set
....17.114 Genomic Molecular Consequence Value Set
....17.115 Genomic Specimen Type Value Set
....17.116 HUGO Gene Nomenclature Committee Gene Names Value Set
....17.117 Human Genome Variation Society Sequence Variant Nomenclature Value Set
....17.118 Histology Morphology Behavior Value Set
....17.119 Specific Diagnosis of Cancer Value Set
....17.120 Laterality Qualifier Value Set
....17.121 Melanoma In-Situ Disorder Value Set
....17.122 Staging Type Value Set (for Distant Metastases Category)
....17.123 Staging Type for Primary Tumor Category Value Set
....17.124 Staging Type for Regional Node Category Value Set
....17.125 Staging Type for Stage Group Value Set
....17.126 Present Absent Value Set
....17.127 Primary Cancer Disorder Value Set
....17.128 Primary Malignant Neoplasm Disorder Value Set
....17.129 Procedure Intent Value Set
....17.130 Radiotherapy Modality Value Set
....17.131 Radiotherapy Technique Value Set
....17.132 Radiotherapy Treatment Location Qualifier Value Set
....17.133 Radiotherapy Treatment Location Value Set
....17.134 Radiotherapy Volume Type Value Set
....17.135 Secondary Cancer Disorder Value Set
....17.136 TNM Distant Metastases Category Value Set
....17.137 TNM Primary Tumor Category Value Set
....17.138 TNM Regional Nodes Category Value Set
....17.139 Carbon Ion Beam Technique Value Set
....17.140 Electron Beam Technique Value Set
....17.141 Teleradiotherapy Modality Value Set
....17.142 Neutron Beam Technique Value Set
....17.143 Photon Beam Technique Value Set
....17.144 Proton Beam Technique Value Set
....17.145 Teleradiotherapy Technique Value Set
....17.146 Treatment Termination Reason Value Set
....17.147 Tumor Marker Test Value Set
....17.148 Tumor Size Method Value Set
....17.149 Tumor Size Units Value Set
....17.150 Requested LOINC Codes Code System
....17.151 Requested SNOMED Codes Code System
....17.152 Search by code:in in Conditions
....17.153 Search by _id in Patients with multipleOr
....17.154 binet-stage-group-A
....17.155 bodyheight-jenny-m-2018-03-06
....17.156 bodyweight-jenny-m-2018-03-16
....17.157 bodyweight-jenny-m-2018-04-22
....17.158 cancer-disease-status-improved
....17.159 cancer-disease-status-jenny-m
....17.160 cancer-patient-adam-everyman
....17.161 cancer-patient-eve-anyperson
....17.162 cancer-patient-jenny-m
....17.163 cancer-patient-john-anyperson
....17.164 cancer-related-mcode-comorbidities-elixhauser-jenny-m
....17.165 cancer-related-mcode-comorbidities-elixhauser-john-anyperson
....17.166 cancer-related-medication-admin-cyclophosphamide-jenny-m
....17.167 cancer-related-medication-admin-doxorubicin-jenny-m
....17.168 cancer-related-medication-admin-paclitaxel-jenny-m
....17.169 cancer-related-medication-request-anastrozole-jenny-m
....17.170 cancer-related-medication-request-cisplatin
....17.171 cancer-related-medication-request-cyclophosphamide-jenny-m
....17.172 cancer-related-medication-request-doxorubicin-jenny-m
....17.173 cancer-related-medication-request-gefitinib
....17.174 cancer-related-medication-request-paclitaxel-jenny-m
....17.175 cancer-related-surgical-procedure-jenny-m
....17.176 cancer-related-surgical-procedure-lobectomy
....17.177 ecog-performance-status-fully-active
....17.178 ecog-performance-status-jenny-m
....17.179 family-member-history-aunt-jenny-m
....17.180 family-member-history-sister-jenny-m
....17.181 family-member-history-uncle-jenny-m
....17.182 genomic-region-studied-jenny-m
....17.183 genomic-region-studied-stk11
....17.184 genomic-specimen-left-breast-jenny-m
....17.185 genomic-specimen-lung
....17.186 genomic-variant-fusion
....17.187 genomic-variant-germline-deletion
....17.188 genomic-variant-jenny-m
....17.189 genomic-variant-somatic-single-nucleotide
....17.190 genomics-report-jenny-m
....17.191 genomics-report-john-anyperson
....17.192 mCODE Patient Group Example
....17.193 jenny-m-chest-wall-lymph-nodes-treatment-volume
....17.194 jenny-m-chest-wall-treatment-volume
....17.195 john-anyperson-treatment-volume
....17.196 karnofsky-performance-status-normal-activity
....17.197 lab-result-observation-hemoglobin
....17.198 mcode-patient-bundle-jenny-m
....17.199 observation-smoking-pack-years-jenny-m
....17.200 primary-cancer-condition-breast
....17.201 primary-cancer-condition-cll
....17.202 primary-cancer-condition-jenny-m
....17.203 primary-cancer-condition-nsclc
....17.204 radiotherapy-treatment-summary-chest-wall-jenny-m
....17.205 secondary-cancer-condition-brain-mets
....17.206 tnm-clinical-distant-metastases-category-cM0
....17.207 tnm-clinical-distant-metastases-category-jenny-m
....17.208 tnm-clinical-primary-tumor-category-cT3
....17.209 tnm-clinical-primary-tumor-category-jenny-m
....17.210 tnm-clinical-regional-nodes-category-cN3
....17.211 tnm-clinical-regional-nodes-category-jenny-m
....17.212 tnm-clinical-stage-group-3c
....17.213 tnm-clinical-stage-group-jenny-m
....17.214 tnm-pathologic-distant-metastases-category-jenny-m
....17.215 tnm-pathologic-primary-tumor-category-jenny-m
....17.216 tnm-pathologic-regional-nodes-category-jenny-m
....17.217 tnm-pathologic-stage-group-jenny-m
....17.218 tumor-lobular-carcinoma-left-breast
....17.219 tumor-marker-test-egf
....17.220 tumor-marker-test-er-jenny-m
....17.221 tumor-marker-test-her2-jenny-m
....17.222 tumor-marker-test-oncotype-dx-jenny-m
....17.223 tumor-marker-test-pr-jenny-m
....17.224 tumor-size-jenny-m
....17.225 tumor-size-pathology
....17.226 tumor-specimen-left-breast-jenny-m
....17.227 tumor-specimen-lobular-carcinoma-left-breast
....17.228 us-core-condition-anxiety-jenny-m
....17.229 us-core-condition-depression-jenny-m
....17.230 us-core-condition-hypertension-jenny-m
....17.231 us-core-diagnosticreport-lab-jenny-m
....17.232 us-core-observation-lab-neutrophils-jenny-m
....17.233 us-core-observation-lab-sentinel-nodes-jenny-m
....17.234 us-core-observation-lab-tumor-dcis-jenny-m
....17.235 us-core-observation-lab-tumor-grade-jenny-m
....17.236 us-core-observation-lab-tumor-invasion-jenny-m
....17.237 us-core-observation-lab-tumor-margins-jenny-m
....17.238 us-core-organization-bedrock-medicine
....17.239 us-core-organization-physician-services-inc
....17.240 us-core-practitioner-jane-radiotech
....17.241 us-core-practitioner-kyle-anydoc
....17.242 us-core-practitioner-mary-obgyn
....17.243 us-core-practitioner-nancy-oncology-nurse
....17.244 us-core-practitioner-owen-oncologist
....17.245 us-core-practitioner-peter-pathologist
....17.246 us-core-procedure-biopsy-jenny-m
....17.247 us-core-procedure-mammogram-jenny-m
....17.248 us-core-smokingstatus-jenny-m
...18 Basic Examples
...19 Extended Example
...20 Data Dictionary
...21 Glossary
...22 Change Log
...23 Download Specification